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Abstract
Background Definitive and high-quality coverage of
large and, in particular, massive skin defects remains a
significant challenge in burn as well as plastic and recon-
structive surgery because of donor site shortage. A novel
and promising approach to overcome these problems is
tissue engineering of skin. Clearly, before eventual clinical
application, engineered skin substitutes of human origin
must be grafted and then evaluated in animal models. For
the various tests to be conducted it is indispensable to be
able to identify human cells as such in culture and also to
distinguish between graft and recipient tissue after trans-
plantation. Here we describe a tool to identify human cells
in vitro and in vivo.
Methods In situ hybridization allows for the detection
and localization of specific DNA or RNA sequences in
morphologically preserved cells in culture or tissue sec-
tions, respectively. We used digoxigenin-labeled DNA
probes corresponding to human-specific Alu repeats in
order to identify human keratinocytes grown in culture
together with rat cells, and also to label split and full
thickness skin grafts of human origin after transplantation
on immuno-incompetent rats.
Results Digoxigenin-labeled DNA probing resulted in an
intensive nuclear staining of human cells, both in culture
and after transplantation onto recipient animals, while
recipient animal cells (rat cells) did not stain.
Conclusion In situ hybridization using primate-specific Alu
probes reliably allows distinguishing between cells of human
and non-human origin both in culture as well as in histolog-
ical sections. This method is an essential tool for those pre-
clinical experiments (performed on non-primate animals) that
must be conducted before novel tissue engineered skin sub-
stitutes might be introduced into clinical practice.
Keywords Tissue engineering  Skin substitute  In situ
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Introduction
Large and especially massive skin defects resulting from
burns, trauma, congenital giant nevi, and disease leading to
skin necrosis, are significant clinical challenges. Clearly,
such defects must be rapidly and definitively covered by
autologous skin tissue. Surgeons are predominantly facing
two problems: donor site shortage in the acute phase of
therapy and scarring in the long run [1]. Especially in
defects exceeding 50–60% of the total body surface area,
donor site shortage is a dramatic and potentially life-
threatening issue [2, 3]. Furthermore, transplanting split-
thickness skin grafts (which is still the gold standard for
coverage of large skin defects), is associated with disabling
and disfiguring hypertrophic scarring or keloid formation,
particularly in children [4, 5]. On the other side, full-
thickness skin transplantation that causes no or only min-
imal scarring, can only be used to cover small defects
(\1% body surface) [1].
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Driven by the hypothesis that laboratory engineered skin
substitutes with near normal anatomy might attenuate both
donor site shortage and scarring [1], we have invested more
than 10 years into tissue engineering of skin (‘‘skingi-
neering’’). We have recently been able to grow dermo-
epidermal skin substitutes of human origin in vitro [6–9].
Obviously, before their eventual clinical application, these
substitutes must be evaluated with regard to various aspects
in pre-clinical trials employing animal models. In this
context, it is indispensable to be able to reliably identify
human cells and tissues both in culture and after
transplantation.
Human DNA contains considerable amounts of primate
genome-specific Alu sequences [10, 11] that can be visu-
alized by in situ hybridization [12]. Here we describe
distinct steps and modifications of this technique to allow
recognition of human cells in our experimental settings.
Materials and methods
Skin specimens
After approval by the Ethics Committee of the Canton of
Zurich and after written informed consent by parents
and/or patients, foreskins following circumcision were
obtained. Samples were either left intact so as to be used as
full thickness skin grafts, or they were cut using a derma-
tome in such a way as to obtain split thickness skin grafts.
Cell cultures
Isolation and culture of human as well as rat keratinocytes
were performed according to standard protocols [7]. Skin
biopsies were digested for 15–18 h at 4C in 12 U ml-1
dispase in Hank’s buffered salt solution containing
5 lg ml-1 gentamycin. Thereafter, epidermis and dermis
were separated using forceps. The epidermis was further
digested in 1% trypsin, 5 mM EDTA for maximally 3 min at
37C. Epidermal cells were resuspended in serum-free
keratinocyte medium containing 25 lg ml-1 bovine pituitary
extract, 0.2 ng ml-1 EGF, and 5 lg ml-1 gentamycin. Cul-
ture medium was changed every 3 days. Rat keratinocytes
were isolated and cultivated in the same way. All compounds
were bought from Invitrogen (Basel, Switzerland).
Transplantation
Anaesthesia for all procedures in rats was performed using
isoflurane (Abbott AG, Baar, Switzerland) according to
defined standards [6].
Full thickness skin defects were created surgically on
the back of 10-week-old female athymic Nu/Nu rats. Then,
polypropylene rings, 27 mm in diameter (modified Fusenig
chamber [13, 14]) were sutured to the wound edges in order
to shelter the wound bed from surrounding skin. Full
thickness or, alternatively, split thickness skin grafts were
then transplanted on the wound bed within the chamber and
covered with Fucidin-Gaze (LEO), Garamycin ointment
(Essex), and N-A Ultra Dressing (Johnson & Johnson).
After 10 days, healed grafts were completely excised and
processed for in situ hybridization.
DNA extraction and probe labeling with digoxigenin
(DIG)
PCR was performed as described by Just [10]. A mix of
175 ng/ml genomic DNA, MgCl2 (25 mM), PCR buffer,
dNTP (10 mM), and Alu-sense and Alu-antisense primer
(each 0.4 lM) was used.
After pre-denaturation at 95C for 5 min, Taq polymer-
ase (2.6 U/ll) was added (‘‘Hot Start’’). Denaturation (95C
for 30 s), hybridization (58C for 45 s), and elongation
(72C for 45 s) were carried out for 25 cycles, followed by a
final elongation for 10 min at 72C [15]. PCR resulted in a
224 bp long fragment of the most conserved areas of human
Alu sequences. The PCR product was electrophoresed on an
agarose gel (2% agarose in 19 TAE, 1.5 lg/ml ethidium
bromide) together with a molecular mass marker (PhiX174
DNA-Hae III). Thereafter, the DNA band of 224 bp was
eluted using the High pure PCR product purification kit
(Roche). To determine the concentration, 5 ll of the PCR
product were electrophoresed on a 2.5% agarose gel in TBE
with 1.5 lg/ml ethidium bromide.
To produce DIG-labeled DNA probes, the same PCR
protocol as described above was used and DIG-labeled
nucleotides (PCR DIG probe synthesis kit (Roche)) were
added. The resulting PCR product was prepared by agarose
gel electrophoresis and the labeled probe was purified
according to the protocol that came with the PCR DIG
probe synthesis kit.
In situ hybridization of cultured cells
Human keratinocytes alone, rat keratinocytes alone, and
both cell types in combination were cultured in a density of
3.4 9 104 cells/chamber on chamber slides (Falcon).
Thereafter, cells were put in a 2 mM calcium-containing
solution for 2 h and then rinsed with PBS.
The cells were fixed in methanol/acetone at -20C for
5 min, air-dried and acetylated twice using TEA buffer for
5 min.
After three washes for 5 min with PBS, the cells were
permeabilized using PBS containing 0.3% Triton X-100,
and thereafter treated with proteinase K (2 ll/ml) in TE
buffer for 30 min at 37C. The proteinase K digestion of
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membrane and cytoskeleton proteins allowed the probe to
enter the nucleus.
After the slides were rinsed again three times for 5 min
in PBS, they were acetylated using acetic anhydride con-
taining TEA buffer to reduce nonspecific binding of the
probe.
The slides were then pre-hybridized in hybridization
buffer for 150 min at 85C in a moist chamber (50%
formamide, 25% H2O, 25% 209 SSC). During the next
2 h, slides were incubated at the same temperature with a
fresh hybridization buffer containing 50 ng/ml denatured
DIG-labeled DNA probe. Thereafter, slides were immedi-
ately transferred into ice for 10 min, to prevent the dena-
turized DNS strands from rehybridizing. After overnight
incubation at 42C, slides were briefly rinsed in 29 SSC at
room temperature and three times in 0.19 SSC for 15 min
at 42C to remove unspecifically bound probe. Detection of
the DIG-labeled DNA probe was performed according to
the protocol of the DIG nucleic acid detection kit (Roche).
Unspecific antibody binding was blocked for 30 min with
blocking buffer (1% blocking reagent (Roche) in maleic
acid buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5) and
then incubated with alkaline phosphatase-conjugated anti-
body solution (1:2,000 in blocking buffer containing 0.1%
Triton X-100) for 1 h.
After rinsing four times with maleic acid buffer for
15 min, slides were rinsed for 5 min in TBS and exposed to
a substrate solution for 2–6 h to allow the color reaction to
occur. To terminate the enzymatic reaction, stop buffer was
added and slides were rinsed three times with PBS, air
dried, and mounted using mounting-medium (Dako).
In situ hybridization of crysections
The excised tissue was embedded in OCT compound
(Sakura Finetek/Digitana AG, Horgen, Switzerland) and
frozen at -20C before being cut into 12 lm sections
using a cryotome. Pre-hybridization and hybridization were
performed as described above. Before mounting, some
cryosections (treated with or without proteinase K) were
stained with Hoechst reagent (1 lg/ml) for 15 min.
In situ hybridization of paraffin sections
Excised tissue specimens were cut into 5 lm thick paraffin
sections using a rotation microtome. Sections were floated
on a 40C water bath containing distilled water before
being transferred onto silane coated glass slides. Tissue
slides were dried at 37C overnight, deparaffinized, and re-
hydrated. Subsequently, slides were processed for pre-
hybridization and hybridization as described above
(including proteinase K treatment to permeabilize cell
membranes).
Results
DNA extraction and probe labeling with DIG
Alu-specific DNA fragments were amplified from human
genomic DNA by PCR. As expected, a band of 245 bp was
detected by electrophoresis (Fig. 1). The oligomers were
isolated, eluted and labeled using a PCR DIG probe syn-
thesis kit (Roche).
In situ hybridization of cultured cells
A first series of in situ hybridization with Alu probes was
successfully carried out on cultured human keratinocytes,
rat keratinocytes, and on co-cultures of both cell types
(Fig. 2). While all nuclei of the cultured human keratino-
cytes exhibited an intensive purple staining (Fig. 2a), rat
keratinocytes did not stain at all (Fig. 2b). Before in situ
hybridization, it was not possible to morphologically
Fig. 1 Agarose gel analysis of PCR products. PCR products were
electrophoretically separated electrophoresed on a 2.5% agarose gel
and visualised by ethidium bromide staining. Lane I ‘‘DNA molecular
weight marker’’ (PhiX174 DNA-Hae III, BioLabs). Lane II Alu DNA
fragment (245 bp, unmarked) Lane III Alu DNA fragment (DIG-
marked). Lane IV ‘‘DNA molecular weight marker’’ (PhiX174 DNA-
Hae III, BioLabs)
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distinguish between human and rat keratinocytes in co-
cultures. Thereafter, distinction was easy and clear cut.
Clusters of human cells exhibiting stained nuclei were
detectable next to unstained, hence Alu-negative, nuclei of
rat keratinocytes (Fig. 2c).
In situ hybridization of cryo- and paraffin tissue
sections
Figure 3 shows a cryo- (Fig. 3a) and a paraffin (Fig. 3b)
section with densely packed nuclei of the living fraction of
keratinocytes. The pictures also reveal that fibroblasts of
human origin are still present in the dermal part of the
grafts. As proteinase K was not used on these sections, the
epidermal and dermal architecture remained largely intact.
However, only the nuclei damaged by sectioning were
accessible for the probe and therefore stained positive. In
contrast, intact nuclei remain unstained, as we demonstrate
using Hoechst staining and microscopical inspection
(Fig. 3c).
In situ hybridization on paraffin sections resulted in an
excellent preservation of the histological structure, even
after proteinase K treatment (Fig. 4). Hematoxylin/eosin
stained histological sections, excised 10 days after trans-
plantation of human split thickness skin, did not allow to
distinguish between human and rat tissue (Fig. 4a). In
contrast, using DIG-labeled DNA probes corresponding to
human specific Alu repeats, clearly revealed the human
cells by their nuclear staining, whereas the cells of the
underlying recipient tissue (of rat origin) did not stain
(Fig. 4b).
Discussion
Here we describe a successfully applied, optimized tech-
nique of in situ hybridization to distinguish between cells
of human and non-primate origin in vitro as well as in
vivo. Generally speaking, our data show that in situ
hybridization using primate-specific Alu probes is a reli-
able tool to selectively recognize human cells in culture
and also after transplanting different types of human skin
grafts onto rats. Although, for the sake of labour and cost
effectiveness, we transplanted split and full thickness skin
grafts and not yet expensive laboratory engineered skin
substitutes, there is little doubt that the method applied
here will work with the same reliability when cultured skin
is used for transplantation.
The described technique has indubitably great value for
a number of crucial preclinical experiments to test labo-
ratory engineered skin substitutes in our well-established
animal model (human cell-derived skin substitutes trans-
planted on athymic rats). For instance, we must study how
these human skin substitutes take on a rat wound bed
during the first days after transplantation (e.g. vasculari-
zation, survival of the epidermis), how they develop and
Fig. 2 Human cells are
selectively recognized using an
Alu probe. a All nuclei of
cultured human keratinocytes
are intensely stained using a
DIG-marked Alu probe. b There
are no Alu sequences in rat
DNA, hence nuclei remain
unstained. c In co-cultures of
human and rat keratinocytes,
clusters of human cells
exhibited stained nuclei,
whereas the nuclei of rat cells
remained unstained
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mature over the ensuing weeks (e.g. tracking the progeny
of human stem cells, maturation of the dermo-epidermal
junction), and what the long-term result after 1 year or
more is going to be. In all these experiments the distinction
between human and rat tissue is definitely essential. The
opportunity to study the biological behavior of laboratory
engineered human skin on a rat host at any given time
desired with the intriguing prospect to always reliably
discern human from host tissue is a promising and needed
prerequisite on the way to clinical application.
With a broader look on the growing field of tissue
engineering, testing of any sort of engineered tissue sub-
stitutes of human origin in immuno-incompetent animal
models will become an indispensable preclinical routine
for analogous reasons as mentioned from our setting. We
therefore anticipate that the approach outlined here might
find widespread application in future tissue engineering
research.
There are a few more aspects calling for a detailed
consideration: basically, there are several methods to dis-
tinguish human and non-primate animal cells including
human specific antibodies, cell detection by the expression
of green fluorescent protein (GFP), labeling of cells with
fluorescence dyes (cell tracking), and, finally in situ
hybridization employing primate-specific Alu sequences
[16–18] as used in our experiments.
Obviously, each technique has particular features that
may be advantageous or disadvantageous depending on the
actual experimental design: for example, antibodies may
cause misleading cross reactions between human and
animal tissue and also yield considerable unspecific back-
ground staining [19]. GFP labeling allows for the moni-
toring of living cells (provided the GFP gene is stably
integrated into the cell’s genome), however, the highly
expressed reporter system might alter cell physiology [19].
After careful evaluation of the above options, we have
chosen in situ hybridization for the following reasons: first,
it can easily, reliably, and without any (potentially harm-
ful) preceding cell manipulation be applied to all human
cells since the Alu-repeats are present in all nucleated
human cells. Second, even degenerated or otherwise
abnormal human cells (pathologic protein synthesis/
Fig. 3 The result of the hybridization depends on the type of section:
12 lm thick cryosections (a) versus 5 lm thick paraffin sections (b).
a Cryosections reveal densely packed purple colored nuclei of the
living fraction of epidermal keratinocytes. It is also obvious that
fibroblasts of human origin are present in the dermal part of the graft
(arrow). Note the partial separation of dermis from epidermis.
b Paraffin sections show basically the same result, except that the
epidermal and dermal architecture remained largely intact. c As
proteinase K was not used on these sections, epidermal and dermal
structures remained largely intact. However, only nuclei damaged by
sectioning were accessible for the probe and therefore stained
positively. Intact nuclei remained unstained. Both nuclear Hoechst
staining and nuclear Alu-signals were superposed (Section 12 lm)
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surface abnormality) can be detected due to their high
content of Alu sequences [20]. Third, labeled Alu probes
can easily and cost-effectively be generated by PCR. Once
the specific probe is produced, it can be used as a template
for further amplification without the need for new genomic
DNA isolation. Since these probes detect highly repetitive
sequences that are more or less statistically distributed
over the genome and found in excess of a million copies,
the resulting signals are much more intense compared to
probes detecting single genes or single chromosomes
[20, 21].
The last comment regards the use of proteinase K and
tissue sectioning. Proteinase K digests cell membranes and
thus acts as a door opener for the probe to enter the
nucleus. But, at the same time, it also gnaws on tissue
integrity. Therefore, we recommend doing paraffin rather
than cryosections, as the former yields more solid tissue
slices (although production of paraffin sections is more
laborious, time-consuming, and also more expensive than
the production of cryosections).
In conclusion, in situ hybridization using primate-
specific Alu probes consistently permits distinction between
human and non-human cells, both in culture as well as
histologically. This technique is an instrumental tool for the
many preclinical experiments that must be accomplished,
testing human cell-derived skin substitutes on non-primate
animals before tissue engineered skin can eventually be
applied clinically.
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